IMIDomics
IMIDomics is a unique company tackling Immune-Mediated Inflammatory Diseases (IMIDs).
IMIDomics has raised €14M across 1 funding round from 4 investors, most recently a round in Jul 2021. Based in Barcelona, Spain; active in Healthtech. Data as of 28 Oct 2026.
Barcelona, Spainwww.imidomics.com ↗
Total raised
€14M
€13,897,077
Funding rounds
1
Investors
4
distinct backers
Active since
2021-07
latest 2021-07
Funding by year
EUR raised per yearIMIDomics — funding by year — interactive chart.
Data table
| IMIDomics — funding by year | |
|---|---|
| 2021 | €14M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-07-29 | Other | €14M | Bristol Myers Squibb,DNS Capital,TAO Capital,The Pritzker Organization | View deal → |
Related news
- https://t.co/jRpZrl6N8It.co · 2021-07
- https://t.co/jRpZrl6N8Iwebcapitalriesgo.com · 2021-07
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel
Global coverage: FundingData